Qualitest was an American pharmaceutical company that produced generic drugs. Qualitest had manufacturing facilities in

Charlotte, North Carolina Charlotte ( ) is the most populous city in the U.S. state of North Carolina. Located in the Piedmont region, it is the county seat of Mecklenburg County. The population was 874,579 at the 2020 census, making Charlotte the 16th-most populo ...

, and Huntsville, AL. In 2010, Qualitest joined Endo International plc – a global specialty healthcare company focused on improving patients’ lives while creating

shareholder value Shareholder value is a business term, sometimes phrased as shareholder value maximization. It became prominent during the 1980s and 1990s along with the management principle value-based management or "managing for value". Definition The term "shar ...

. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic and device products through its operating companies. Endo has global headquarters in Dublin, Ireland and US headquarters in Malvern, PA. DAVA Pharmaceuticals, Inc. became part of Qualitest Pharmaceuticals, an Endo International plc company. Boca Pharmacal was a specialty generics company with a unique generics product portfolio and complementary pipeline that builds on Qualitest’s strength in controlled substances.

Timeline

*1983: Founded as a generic product distribution joint venture with Kmart * 1986: Company is named Qualitest and moved to Huntsville, Alabama * 1992: Charlotte, North Carolina facility purchased from Medico Pharma; manufacturing company named Vintage, Inc. * 1996: Liquid plant built in Huntsville and rolled into Vintage, Inc. * 2001: Tabled plant headquarters and distribution buildings built. * 2007: Company purchased by Apax® and ranked 7th largest generics company in the United States. * 2010: On December 1, 2010, Qualitest Pharmaceuticals becomes a wholly owned subsidiary of

Endo Pharmaceuticals Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost ...

. Qualitest is ranked the 5th largest generics company in the United States. * 2014: On February 3, 2014, Endo successfully completed its acquisition of specialty generics company Boca Pharmaca. Boca Pharmacal Inc. (Boca), the specialty generics company, was acquired by Endo in February 2014 and is now part of Qualitest. Boca focuses on niche areas, including controlled substances, semi-solid drugs and solutions. On August 6, 2014, Endo completed its acquisition of DAVA Pharmaceuticals, Inc., a privately held company specializing in generic pharmaceuticals. The acquisition of DAVA Pharmaceuticals Inc., in August 2014, adds a high-margin generics portfolio and robust near-term generics pipeline to the Qualitest business * 2015: Endo acquires Auxilium Pharmaceuticals, Inc. as part of Endo Pharmaceuticals business. In May, 2015 Endo International plc (NASDAQ: ENDP) (TSX: ENL) and

Par Pharmaceutical Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost ...

Holdings, Inc. announced that they have entered into a definitive agreement under which Endo will acquire privately held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Qualitest subsequently merged into Par in July 2016 which effectively dissolved Qualitest as a company.

Lawsuit

In 2015, over one hundred women have filed legal action against the company.

References

{{Pharmaceutical companies of the United States Pharmaceutical companies disestablished in 2016 Pharmaceutical companies of the United States Companies based in Huntsville, Alabama Health care companies based in Alabama